glp 1 gip agonist Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes Potential Use of GLP-1 and

Semaglutide is an active ingredient from the group of so-called GLP-1 receptor agonists

While some physicians are prescribing these medications for their approved uses of treating type 2 diabetes, obesity and obstructive sleep apnea, others are frequently making off-label prescriptions

-Enatides have not been shown to reduce risk of stroke or myocardial infarction

Nonetheless, the effect of GLP-1 RAs on HR should not be overlooked, because studies have shown that an elevated HR was potentially associated with a higher cardiovascular risk [353637]

Everyday Health

10.1002/(SICI)1096-9861(19990111)403:2 3.0.CO;2-5 [DOI] [PubMed] [Google Scholar] Miller R